Skip to main content
. Author manuscript; available in PMC: 2008 Sep 1.
Published in final edited form as: Biol Blood Marrow Transplant. 2007 Jul 20;13(9):1041–1048. doi: 10.1016/j.bbmt.2007.05.011

Figure 1.

Figure 1

Cumulative incidences of grades II acute GVHD (A), III-IV acute GVHD (B) and chronic extensive GVHD (C) in patients included in the current protocol (protocol #1668; extended MMF and truncated CSP, n=71), or in the historical protocol (protocol #1641; n=103). Progression-free survival in patients included in the current protocol or in the historical protocol (D). Cumulative incidences of nonrelapse mortality in the current and in the historical protocols among patients who experienced (E) or did not experience (F) grade II-IV acute GVHD before day 80.